Leyla Demir

534 total citations
23 papers, 256 citations indexed

About

Leyla Demir is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Leyla Demir has authored 23 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Physiology. Recurrent topics in Leyla Demir's work include Nuclear Structure and Function (6 papers), Diabetes and associated disorders (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Leyla Demir is often cited by papers focused on Nuclear Structure and Function (6 papers), Diabetes and associated disorders (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Leyla Demir collaborates with scholars based in Türkiye, United Kingdom and Italy. Leyla Demir's co-authors include Tevfik Demir, Recep Sütçü, Utku Oflazoğlu, Asuman Deveci Özkan, Canan Altay, İlgın Yıldırım Şimşir, Ayşenur Atay, Serap Çuhadar, Hüseyin Önay and Saliha Aksun and has published in prestigious journals such as European Journal of Cancer, Metabolism and Diabetic Medicine.

In The Last Decade

Leyla Demir

20 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leyla Demir Türkiye 9 108 102 36 36 33 23 256
Melanie Eggermont Belgium 11 110 1.0× 74 0.7× 37 1.0× 54 1.5× 17 0.5× 14 335
Omama Helal United Kingdom 3 110 1.0× 123 1.2× 15 0.4× 35 1.0× 26 0.8× 4 306
Seong Beom Cho South Korea 9 92 0.9× 57 0.6× 13 0.4× 55 1.5× 30 0.9× 19 283
N. Bellili France 9 104 1.0× 70 0.7× 55 1.5× 60 1.7× 98 3.0× 11 290
Haoning Howard Cen Canada 9 101 0.9× 59 0.6× 22 0.6× 35 1.0× 63 1.9× 13 203
Lotte Krogh Denmark 6 75 0.7× 33 0.3× 25 0.7× 54 1.5× 37 1.1× 15 179
Sinan Tanyolaç Türkiye 7 97 0.9× 39 0.4× 36 1.0× 30 0.8× 45 1.4× 11 264
A. Bertacca Italy 7 82 0.8× 101 1.0× 14 0.4× 23 0.6× 49 1.5× 10 282
Bethan L. Clifford United Kingdom 12 106 1.0× 58 0.6× 37 1.0× 18 0.5× 68 2.1× 15 342
Rufei Shen China 10 111 1.0× 90 0.9× 16 0.4× 33 0.9× 67 2.0× 19 336

Countries citing papers authored by Leyla Demir

Since Specialization
Citations

This map shows the geographic impact of Leyla Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leyla Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leyla Demir more than expected).

Fields of papers citing papers by Leyla Demir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leyla Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leyla Demir. The network helps show where Leyla Demir may publish in the future.

Co-authorship network of co-authors of Leyla Demir

This figure shows the co-authorship network connecting the top 25 collaborators of Leyla Demir. A scholar is included among the top collaborators of Leyla Demir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leyla Demir. Leyla Demir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Demir, Leyla & Utku Oflazoğlu. (2023). The relationship between sarcopenia and serum irisin and TNF-α levels in newly diagnosed cancer patients. Supportive Care in Cancer. 31(10). 586–586. 7 indexed citations
3.
Demir, Leyla, et al.. (2023). Presence of macroproteins on the measurement of vitamin B12: studying high vitamin B12 levels using polyethylene glycol and heterophile antibody blocking tubes. Scandinavian Journal of Clinical and Laboratory Investigation. 83(2). 125–132. 2 indexed citations
4.
Uysal, Sezer, Tevfik Demir, Yücel Demıral, et al.. (2021). Associations Between Bioavailable Vitamin D and Remnant Cholesterol in Patients With Type 2 Diabetes Mellitus. Cureus. 13(2). e13248–e13248. 7 indexed citations
5.
Demir, Leyla, Umut Varol, Kemal Atahan, et al.. (2020). Preliminary study of serum Galectin-1 in breast cancer carcinogenesis [Izmir Oncology Group (IZOG) study].. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(2). 675–680. 3 indexed citations
6.
Altay, Canan, Mustafa Seçil, Başak Özgen Saydam, et al.. (2020). Magnetic resonance spectroscopy to assess hepatic steatosis in patients with lipodystrophy. The Turkish Journal of Gastroenterology. 31(8). 588–595. 2 indexed citations
7.
Altay, Canan, Mustafa Seçil, Tevfik Demir, et al.. (2017). Determining residual adipose tissue characteristics with MRI in patients with various subtypes of lipodystrophy. Diagnostic and Interventional Radiology. 23(6). 428–434. 21 indexed citations
8.
Akıncı, Gülçin, Haluk Topaloğlu, Tevfik Demir, et al.. (2017). Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: A multicenter study. Neuromuscular Disorders. 27(10). 923–930. 22 indexed citations
9.
Salman, Tarık, Leyla Demir, Umut Varol, et al.. (2017). Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor.. PubMed. 21(6). 1419–1424. 18 indexed citations
10.
Yener, Serkan, Leyla Demir, Mustafa Barış, et al.. (2017). Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism. Endocrine. 56(2). 308–316. 21 indexed citations
11.
Yıldız, Yaşar, Yüksel Küçükzeybek, Ahmet Alacacıoğlu, et al.. (2017). SERUM LEVELS OF OMENTIN-1 IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER: THE IZMIR ONCOLOGY GROUP (IZOG) STUDY. 4 indexed citations
12.
Demir, Tevfik, Barış Akıncı, Leyla Demir, et al.. (2016). Partial lipodystrophy of the limbs in a diabetes clinic setting. Primary care diabetes. 10(4). 293–299. 2 indexed citations
13.
Salman, Tarık, Leyla Demir, Çağatay Arslan, et al.. (2016). Thrombin activatable fibrinolysis inhibitor (TAFI), tissue factor pathway inhibitor (TFPI), and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer. Acta Oncologica Turcica. 49(1). 6–12. 2 indexed citations
14.
15.
Demir, Tevfik, Hüseyin Önay, David B. Savage, et al.. (2015). Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor-[gamma] mutation, H449L. Endocrine Abstracts. 1 indexed citations
16.
Akıncı, Barış, Hüseyin Önay, Sevgi Yavuz, et al.. (2015). Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities. Metabolism. 64(9). 1086–1095. 24 indexed citations
17.
Akyol, Murat, Leyla Demir, Ahmet Alacacıoğlu, et al.. (2015). The Effects of Adjuvant Endocrine Treatment on Serum Leptin, Serum Adiponectin and Body Composition in Patients with Breast Cancer: The Izmir Oncology Group (IZOG) Study. Chemotherapy. 61(2). 57–64. 17 indexed citations
18.
Akyol, Murat, Leyla Demir, Ahmet Alacacıoğlu, et al.. (2015). 1953 The effects of adjuvant endocrine treatment on the serum leptin, adiponectin and body composition in patients with breast cancer [Izmir Oncology Group(IZOG) Study]. European Journal of Cancer. 51. S317–S317. 1 indexed citations
19.
Demir, Leyla, Başak Toğar, Hasan Türkez, et al.. (2015). The investigation of cytogenetic and oxidative effects of diffractaic acid on human lymphocyte cultures. Brazilian Archives of Biology and Technology. 58(1). 75–81. 8 indexed citations
20.
Atay, Ayşenur, Leyla Demir, Serap Çuhadar, et al.. (2014). Clinical biochemistry laboratory rejection rates due to various types of preanalytical errors. Biochemia Medica. 24(3). 376–382. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie Eggermont Breakdown of academic impact, for papers by Omama Helal Breakdown of academic impact, for papers by Seong Beom Cho Breakdown of academic impact, for papers by N. Bellili Breakdown of academic impact, for papers by Haoning Howard Cen Breakdown of academic impact, for papers by Lotte Krogh Breakdown of academic impact, for papers by Sinan Tanyolaç Breakdown of academic impact, for papers by A. Bertacca Breakdown of academic impact, for papers by Bethan L. Clifford Breakdown of academic impact, for papers by Rufei Shen
Rankless by CCL
2026